These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2523101

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tolerance to class II major histocompatibility complex molecules is maintained in the presence of endogenous, interleukin-2-producing, tolerogen-specific T lymphocytes.
    Mohler KM, Streilein JW.
    J Immunol; 1987 Oct 01; 139(7):2211-9. PubMed ID: 2958541
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differential expression of helper versus effector activity in mice rendered neonatally tolerant of class II MHC antigens.
    Mohler KM, Streilein JW.
    Transplantation; 1989 Apr 01; 47(4):633-40. PubMed ID: 2523102
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cellular mechanisms that maintain neonatally-induced tolerance of class II alloantigens. Evidence that precursor cytotoxic T cells are present but silenced.
    Matriano JA, Socarras S, Streilein JW.
    J Immunol; 1994 Aug 15; 153(4):1515-26. PubMed ID: 8046230
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clonal analysis of helper and effector T-cell function in neonatal transplantation tolerance: clonal deletion of helper cells determines lack of in vitro responsiveness.
    Wood PJ, Strome PG, Streilein JW.
    Immunogenetics; 1984 Aug 15; 20(2):185-96. PubMed ID: 6236147
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The influence of allo-class II MHC-specific Th2 cells on the generation of CD4 and CD8 cytotoxic T cells to associated class I and class II MHC alloantigen.
    Wood PJ, Cossens IA.
    Clin Exp Immunol; 1995 May 15; 100(2):359-65. PubMed ID: 7743677
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cognate interactions between helper T cells and B cells. III. Contact-dependent, lymphokine-independent induction of B cell cycle entry by activated helper T cells.
    Noelle RJ, McCann J, Marshall L, Bartlett WC.
    J Immunol; 1989 Sep 15; 143(6):1807-14. PubMed ID: 2476483
    [Abstract] [Full Text] [Related]

  • 13. Analysis of immunological tolerance to major histocompatibility complex antigens. I. High frequencies of tolerogen-specific cytotoxic T lymphocyte precursors in mice neonatally tolerized to class I major histocompatibility complex antigens.
    Heeg K, Wagner H.
    Eur J Immunol; 1985 Jan 15; 15(1):25-30. PubMed ID: 2578397
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.
    Sato S, Azuma T, Shimizu J, Shima J, Kitagawa S, Hamaoka T, Fujiwara H.
    J Immunol; 1988 Aug 01; 141(3):721-7. PubMed ID: 2456330
    [Abstract] [Full Text] [Related]

  • 19. The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytes.
    De Wit D, Van Mechelen M, Ryelandt M, Figueiredo AC, Abramowicz D, Goldman M, Bazin H, Urbain J, Leo O.
    J Exp Med; 1992 Jan 01; 175(1):9-14. PubMed ID: 1370533
    [Abstract] [Full Text] [Related]

  • 20. Characterization of antigen-specific CD4+ effector T cells in vivo: immunization results in a transient population of MEL-14-, CD45RB- helper cells that secretes interleukin 2 (IL-2), IL-3, IL-4, and interferon gamma.
    Bradley LM, Duncan DD, Tonkonogy S, Swain SL.
    J Exp Med; 1991 Sep 01; 174(3):547-59. PubMed ID: 1678774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.